Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1d1750b578ca9a780678f6b9b9c8b87d |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-563 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-563 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
filingDate |
2020-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49ac633603350abe617b969121293477 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53d49e405813bdbad7faa82d3d49c93b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aabe072da4b42c9ab85968fff43f19a7 |
publicationDate |
2021-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20210152859-A |
titleOfInvention |
GRP94 specific antibody or antigen-binding fragment thereof and uses thereof |
abstract |
The present invention relates to an antibody or antigen-binding fragment thereof that specifically binds to GRP94 and uses thereof. The GRP94 antibody or antigen-binding fragment thereof according to the present invention has very high specificity and affinity for GRP94, and has excellent growth inhibitory effect, invasion inhibitory effect, and angiogenesis inhibitory effect on colorectal cancer cell lines. It can be usefully used as a composition for treatment, inhibition of cancer metastasis, and inhibition of angiogenesis. |
priorityDate |
2020-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |